IGM Biosciences, Inc. will be reducing its workforce by approximately 22%. As a result of these actions, the company expected to extend its cash runway into the second quarter of 2026.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.08 USD | -3.46% | -11.58% | -2.11% |
May. 09 | RBC Cuts Price Target on IGM Biosciences to $20 From $21, Keeps Outperform, Speculative Risk | MT |
May. 08 | Earnings Flash (IGMS) IGM BIOSCIENCES Posts Q1 Collaboration Revenue $497,000 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.11% | 494M | |
+8.21% | 115B | |
+12.94% | 107B | |
-13.61% | 22.31B | |
-3.99% | 21.6B | |
-5.76% | 18.23B | |
-39.93% | 17.62B | |
+7.30% | 14.26B | |
+33.58% | 12.37B | |
-28.00% | 8.28B |
- Stock Market
- Equities
- IGMS Stock
- News IGM Biosciences, Inc.
- Igm Biosciences, Inc. to Reduce its Workforce by Approximately 22%